Member-only story
Clinical trials on promising new all-cancer cure likely to begin this year
This appeared in The Millennial Source
Recent advancements in an immune cell cancer treatment made by a Cardiff University team has found a new part of our immune system that can be used to treat all cancers.
The study is still in its preliminary stages and has yet to be tested on people.
Although “promising,” however, researchers say it would take “many years” for the new immune cell cancer treatment, which can reportedly attack a variety of cancers without needing tailored treatment, to be made available to the public.
Cardiff University researcher Professor Andrew K. Sewell told The Millennial Source that only a handful of patients will be selected to undergo a series of clinical trials set to begin as early as late this year.
“While we hope to enter clinical trials later this year or early next year, this will be for a handful of patients in-series. It is important that we know the therapy is safe and there is an established, standard pipeline to follow for this,” Sewell said.
The treatment has yet to be tested on a patient and is only “promising basic science result in the laboratory,” Sewell said.
